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Distinct pattern of matrix metalioproteinase 9 and tissue inhibitor of
metalloproteinase 1 mRNA expression in human colorectal cancer and
liver metastases
ZS Zeng and JG Guillem
Colorectal Service, Department ofSurger., Memorial Sloan-Kettering Cancer Center, 1275 York Aivenue. New York. New York
10021, US.4.
Summarv The matnrx metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are
perceived as essential for tumour invasion and metastasis. In the present study. we compare the topographical
pattern of MMP-9 and TIMP-1 expression in colorectal cancer and liver metastases bv in situ hvbridisation.
TIMP-1 mRNA was detected in all 26 colorectal cancers examined. while onls 18 out of 26 (69.200) were
positive for MMP-9. Both MMP-9 and TIMP-1 mRNA were observed in all ten liver metastases but were
absent in three adenomas and in all normal colonic mucosa and liver. There u-as no association between
MMP-9 or TIMP-1 mRNA expression and degree of differentiation or size of tumours. MMP-9 and TIMP-1
mRNA were similarlv observed in the peritumour stroma cells rather than in tumour cells themselves. MMP-9
mRNA-positive cells were round and identified as macrophages bv immunostaining with an anti-macrophage
antibodv (KP1). while TIMP-1 mRNA was detected in spindle-shaped stromal cells In liser metastases
MMP-9 localised Within peritumour stroma or at the interface between the tumour stroma and normal liver.
whereas TIMP-1 mRNA was located throughout the malignant tumour stroma. Our data demonstrate a
distinct pattern of MMP-9 and TIMP-1 mRNA expression in colorectal cancer and liver metastases suggesting
distinct cellular origins as well as separate patterns of regulation.
Kewords: in situ hvbridisation; matrix metalloproteinase: tissue inhibitor of metalloproteinase: type IV
collagenase
Matrix metalloproteinases (MMPs) are a famils of metal-
dependent endopeptidases with proteolytic activities for
various components of the extracellular matrix (Liotta and
Stetler-Stevenson. 1991; Ennis and Matrisian. 1994). The
MMP family comprises at least nine members (Woessner.
1994). All family members are secreted in a latent form that
becomes active upon cleavage of a 10 000 dalton peptide
(Ennis and Matrisian. 1994). Since type IV collagen is a
major component of basement membranes, the 72 kDa
(MMP-2) and 92 kDa (MMP-9) type IV collagenases are of
particular interest.
Over the last decade. much attention has focused on the
role of MMPs in tumour invasion and metastases (Liotta and
Stetler-Stevenson. 1991: Murphy et al.. 1989). Both in vitro
and in vivo data have indicated that MMPs participate. via
accelerated breakdown of extracellular matrices. in tumour
invasion and metastases (Liotta et al.. 1980: Nakajima et al..
1987: Ura et al.. 1989). Furthermore. increased production of
MMP has been associated with increased invasive and metas-
tatic potential in several human malignant tumours (Levy et
al.. 1991: Urbanski et al.. 1992; Boag and Young, 1993:
Brown et al.. 1993). Although. MMP-9 is secreted by a wide
range of cells. including macrophages, neutrophils. capillary
endothelial cells and trophoblasts. from both normal and
malignant tissue (Hibbs et al.. 1985. 1987: Herron et al..
1988: Werb and Alexander. 1993) in primary colorectal
cancer. it appears that MMP-9 mRNA may be macrophage
in origin (Pyke et al., 1993).
MMP activity, in vivo. is thought to be regulated in part by
natural tissue inhibitor proteins such as tissue inhibitors of
metalloproteinases (TIMP) (Liotta and Stetler-Stevenson.
1991: Ennis and Matrisian. 1994). Thus far. three TIMP
genes (TIMP-1. TIMP-2 and TIMP-3) have been identified
(Murphy et al.. 1981: Stetler-Stevenson et al.. 1989: Pavloff et
al.. 1992). TIMP-1 is a glycoprotein with an apparent
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molecular size of 28.5 kDa and is produced by a variety ot
human tissues and many human tumour cell lines (Murphy et
al.. 1981: Stricklin and Welgus. 1983: Dean et al.. 1992: Sato
et al.. 1992). TIMP-1 inhibits MMPs by forming a 1:1 com-
plex with activated MMP-1. MMP-3 and MMP-9 (Liotta
and Stetler-Stevenson. 1991: Ennis and Matrisian.. 1994).
Although several studies have shown an inverse correlation
between TIMP-1 levels and the metastatic potential of
murine and human tumour cells (Schultz et al.. 1988:
Khokha et al.. 1989: Alvarez et al.. 1990). we and others
have demonstrated a direct correlation between TIMP-1 exp-
ression and clinical aggressiveness of colorectal cancer
(Guillem et al.. 1990: Lu et al.. 1991: Zeng et al.. 1995).
Recently. using Northern blot analysis of whole-tissue
homogenates. we demonstrated a parallel overexpression of
TIMP-1 and MMP-9 mRNA in colorectal cancer and liver
metastases. suggesting co-regulation of these two genes (Zeng
et al., 1993). However. because of tissue cellular hetero-
geneity. the exact cellular origin of TIMP-1 and MMP-9
mRNA in colorectal cancer and liver metastases homo-
genates remained unclear. In the present study. in situ hyb-
ridisation analysis was used to investigate the cellular dist-
ribution of TIMP-1 and MMP-9 mRNA expression in
human colorectal cancer and liver metastases.
Materials and methods
Tissue samples
All surgical samples used in this study were randomly
obtained from the operating room immediately after resec-
tion. Eighteen primary colorectal cancers and corresponding
normal mucosa and seven colorectal cancer liver metastases
and matched normal liver were examined by Northern blot
analysis. In addition. 26 primary colorectal cancers. three
benign adenomas and ten liver metastases as well as corres-
ponding normal adjacent tissue were examined by in situ
hybridisation. Table I summarises the clinicopathological
variables of these 26 primary colorectal cancers. The Sur-
gical Pathological Laboratory' of the Memorial Sloan-~-9 andTIW-2 o iniamc~n w
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Table I Clim pathological c rstics of26colorectalcancrs and ai situ MMP-9 and
TIMP-I hybridiation status
Case
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Age
80
65
66
78
71
54
81
55
64
63
72
67
64
32
77
47
75
78
74
62
62
86
50
69
71
74
Sex
F
F
F
M
M
M
F
F
F
M
F
M
M
F
M
M
M
M
F
M
F
M
M
F
F
F
Locatione
RE
RS
R
RS
RE
RE
S
R
S
R
RE
S
R
RC
R
S
RE
RE
R
R
R
R
L
L
R
RC
Dt7
M
M
M
M
M
p
p
M
M
M
M
M
M
M
M
M
M
M
M
p
M
M
M
M
M
M
Size (cm)
(Max)
6.5
4.0
4.0
4.8
3.5
7.0
3.2
6.0
2.5
5.0
10.0
4.5
3.0
4.5
3.2
6.0
6.5
7.5
3.6
10.0
9.0
6.0
3.0
3.7
4.5
7.0
Dukes'
stage
C
A
C
D
A
D
C
B
B
C
D
D
A
D
B
D
B
C
A
D
D
B
D
C
A
C
In Situ
h ybiisto
TIMP-1 MMP-9
+ +
+_
+_
+ +
+_
+ +
+ +
+ +
+_
+ +
+ +
+ +
+_
+ +
+_
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+_
+_
+ +
'R, right colon; L, left colon; S, sigmoid colon; RS, rectum-sigmoid colon; RE, rectum.
bDiffrefers to tumour differentiation: M, moderate; P, poor.
Kettering Cancer Center (MSKCC) performed routine
histopathological examination on the resected specimens
using haematoxylin and eosin staining.
Tissue processing
Northern blot analysis Specimens obtained from the
tumour edge, avoiding a necrotic centre, were quick-frozen
in liquid nitrogen and stored at -80-C. Samples were
handled and stored under strict RNAse-free conditions.
Samples of normal mucosa were obtained from the surgical
resection margin by sharply dissecting the mucosa off the
muscularis.
In situ analysis Specimens were fixed in 4% parafor-
maldehyde overnight at 4-C, sequentially dehydrated with
50%, 70%, 85%, 95% and 100% ethanol and embedded in
paraffin. To prevent RNA degradation, reagents were
treated with diethyl pyrocarbonate (0.1%).
Preparation ofRNA probes
Sense and antisense 35S-labelled RNA probes were prepared
from human TIMP-1 and MMP-9 cDNAs cloned in Blue-
script KS (Stratagene). The TIMP-1 sense probe was
generated by T3 polymerase following digestion with KpnL,
while the anusense probe was generated by T7 polymerase
after EcoRI template digestion. For MMP-9 RNA probes,
sense and antisense plasmid vectors were linearised with
XbaL and EcoRI respectively. Transcribed RNA was labelld
with [_-355NUTP (1200 Ci mmol-', Dupont, NEW). DNA
template was removed by incubating with RNAse-free
DNAse. Ten micrograms of tRNA was added and samples
were extracted with phenol-chloroform. RNA probes were
hydrolysed with sodium carbonate buffer, pH 10.2, for
60 min at 60-C, neutralised and ethanol precipitated. Probes
were redissolved in 10 mM DTT at a final concentration of
1.5ngfl-1 and stored at -20-C.
In situ hybridisation
Prehybridisation Paraffin sections 5-10 Ipm thick were dried
at 42-C overnight, deparaffinised in xylene and then redehy-
drated by passage through graded ethanol. Slides were
incubated with protenase K(1O0jigm[-') at room temp-
erature for 7.5 min and then serially dipped in PBS, washed
in 2 mgml-' glycine (w/v) and finally washed in freshly
prepared tnethanolami buffer containing 0.25% acetic
anhydride for Omin.
Hybridisation The labelled probes were diluted in hybrid-
isation buffer containing 50% foiamide, 10% dextran sul-
phate, 0.1 M DiT and Denhardt's. 35S-abelled RNA probe
was added to each slide in a 25pl volume of hybridisation
mixture. The slides were covered with coverslip and in-
cubated at 57C overnight in a 50% formamie, 2 x SSC
humidified chamber.
Post-hybridisation After hybridisation, coverslips were gent-
ly removed with 4 x SSC and slides washed at room
temperature in 4 x SSC for 1 h and then in 2 x SSC, 50%
formamide, 10mM DTT solution for 40min at 68-C. Slides
were then treated with 20zgml 1 RNAseA in 20mm Tris,
pH 7.5, 0.5M sodium chloride, 1 mm EDTA at 3TC for
30 min followed by washing in the same buffer without
RNAse A for 30min. The final washes were in 2 x SSC, 50%
formamide, 1 mM DTT for 40min at 68-C, 2 x SSC for
5 mnm at room temperature and 0.1 x SSC for 15 min at
50-C. Slides were dehydrated through graded ethanol and air
dried
Autoradiography Autoradiographic detection of the hybrids
was carried out by dipping in Kodak NTB-2 emulsion (East-
man Kodak, Rochester, NY, USA) at 42C under safe light
and dried at room temperature for at lat 2 h. Sldes were
placed in a light tight box at 4-C for 1-2 weeks. After
exposure, sLides were subsequently developed m Kodak D-19
developer for 4min at 15'C, washed in water and fixed in
Kodak fixer. Tissue sections were counterstained with
haematoxylin and eosin (H&E) and mounted. Silver grains
were visualised by dark-field microscopy (Nikon).
Northern blot hybridisation
RNA was extracted by the guanidium isocyanide/caesium
chloride method as previously described (Zeng et al., 1994a).
Ten micrograms of total RNA was electrophoresed on 1.0%
agarose-formaldehyde gel and blotted onto a Duralon-UVMMP-9 and T1MP-1 mRNA in colon cancer and rw meastses
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membrane (Stratagene). TIMP-1 and MMP-9 DNA probes
were radiolabelled with [32PJdCTP by the random primer
technique (Feinberg and Vogelsteim, 1983). A 28S oligo probe
was used as an internal control (Barbu and Dautry, 1989) for
equal RNA loading and ethidium bromide staining of gels to
confirm equal RNA transfer. Hybridised RNA was quan-
titated by LKB XL laser densitometry (Pharmacia LKB
Biotechnology, Uppsala. Sweden). The results were expressed
as a ratio of the average fold increase of transcript in
tumours to that in the paired normal tissues. The difference
in standardised TIMP-1 and MMP-9 between tumour and
paired normal tissue was assessed by the paired t-test.
Significant differences were analysed by Student's t-test.
Immunohistochemistrn
Tissue sections adjacent to those used for in situ hybridisa-
tion were used for immunohistochemistry. Tissue mac-
rophages were identified by peroxidase-antiperoxidase immn-
unostaining using a monoclonal anti-macrophage antibody
KP-1 (CD-68). This antibody is known to react specifically
with tissue macrophages (Pulford et al., 1989). The immuno-
histochemical staining technique was performed as previously
descnrbed (Zeng et al., 1994b).
Results
Expression ofMMP-9 and TIMP-J in colorectal cancer and
liver metastases
Northern blot analysis of both MMP-9 and TIMP-1 in 18
primary colorectal cancers and matched adjacent normal
mucosa as well as seven colorectal cancer liver metastases
and matched normal liver revealed a parallel overexpression
of MMP-9 and TIMP-1 mRNA in both human colorectal
cancer and liver metastases (Figure 1). The mean tumour,'
normal (T/N) fold increases of TIMP-1 and MMP-9 in
primary cancer were 9.1 ± 1.9 (P<0.01) and 12.9 ± 5.0
(P<0.01), while in liver metastases they were 11.1 ± 3.6
(P<0.05) and 3.47 ± 1.2 (P<0.05) respectively.
In situ hkbridisation ofMMP-9 and TIMP-J mRNA in
primary colorectal cancer
As seen in Figure 2, primary colorectal cancers show detec-
table signals for MMP-9 and TIMP-1 mRNA. All 26 col-
orectal cancers were positive for TIMP-1 expression, while
only 18 out of 26 (69.2%) colorectal cancers were positive for
MMP-9 (Table I). Intensity of staining varied between
different cases and in different areas of the same tumour. In
three adenomas and in corresponding normal mucosa.
insignificant (background) quantities of MMP-9 and TIMP-1
mRNA were detected and the control sense probes for
MMP-9 and TIMP-1 showed only background autographic
signals (figures not shown). Since silver grain signals occurred
only with the antisense probe and none were detected with
the sense probe, the hybridisation was felt to be specific.
The correlation between MMP-9 and TIMP-1 mRNA exp-
ression in 26 colorectal cancer specimens and the relationship
to clinicopathological variables is summarised in Table I.
MMP-9 and TIMP-1 mRNA expression did not correlate
with either the degree of tumour differentiation or the size of
the tumours. Figure 3 shows MMP-9 mRNA expression in
relation to Dukes' stage. MMP-9 mRNA expression progres-
sively increased with advancing stages (Dukes' A to 'Dukes'
D).
In situ hybridisation ofMMP-9 and TIMP-J mRNA in
colorectal cancer liver metastases
In situ hybridisation analysis revealed a remarkably specific
signal for MMP-9 (Figure 4) and TIMP-1 (Figure 5) mRNA
transcripts in all ten liver metastases from colorectal cancer.
No expression was detected in adjacent normal liver and
hybridisations with MMP-9 and TIMP-1 sense probes were
also negative (data not shown).
Distinct localisation ofMMP-9 and TIMP-J expression
Although both MMP-9 and TIMP-1 mRNA signals were
strongest within stromal cells of tumours, the spatial distribu-
tions of MMP-9 and TIMP-1 mRNA were distinctlv
different. In order to compare directly the spatial expression
of MMP-9 and TIMP-1. we hybridised serial sections of the
same samples. As seen in serial sections (Figure 2). MMP-9
mRNA hybridisation resulted in a more focused signal.
strongest within a small population of stromal cells encircling
the tumour epithelial cells (Figure 2b and c), whereas TIMP-
1 mRNA hybridisation produced a diffuse scattering signal
(Figure 2e and f).
The general expression patterns of MMP-9 and TIMP-1
mRNA in liver metastases were similar to those in primarn
colorectal cancers. Comparison of MMP-9 and TIMP-1
mRNA expression in liver metastases indicates that, although
hybridisation signals for MMP-9 and TIMP-1 transcripts
were clearly localised in tumour stroma, MMP-9 and TIMP-1
mRNA have distinctly different patterns of distribution. As
seen in Figure 4a and b. large numbers of MMP-9-positive
cells were localised at the interface between the liver met-
astases lesion (LM) and surrounding normal liver paren-
chyma (NL). However, TIMP-1 mRNA was found through-
out malignant tumour stroma (Figure 5a and b).
Higher magnifications of the area bordered by arrows in
Figure 2b and e are shown in Figure 2c and f. The MMP-9
mRNA signals were seen in a small population of stromal
cells encircling the tumour epithelial cells (Figure 2c).
whereas TIMP-1-labelled cells are clearly spindle-shaped
stromal cells (Figure 2f). When seen in liver metastases
under higher magnification. MMP-9 mRNA-positive stroma
cells (Figure 4b, arrow marked) have a circular pattern
(Figure 4c), while TIMP-l-positive cells (Figure Sb. arrow
marked) are spindle like in shape (Figure Sc).
To identify the cells expressing MMP-9 mRNA three
colorectal cancer and two liver metastases samples were
examined by immunohistochemical staining with the mono-
clonal antibody KPl (CD68). known to be macrophage
specific (Pulford et al.. 1989). Figure 6 shows that cells
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Figure 1 MMP-9 and TIMP-1 expression in colorectal cancer and liver metastases from colorectal cancer. MMP-9 and TIMP-1
cDNA probe co-hybridisation was performed from tumour and adjacent normal tissue (T. tumour: N. normal mucosa: M. liver
metastases: L. normal liver tissue). Blots were subsequently stripped and reprobed vwith the 28S probe.MMP-9 and TIMP-1 mRNA in colon cancer and liver metastases
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Figure 2 Microphotographs showing in situ hybridisation for TIMP-1 and MMP-9 in serial sections of primary human colon
cancer. Bright-field and corresponding dark-field microphotography of MMP-9 mRNA (a, b and c) and TIMP-1 mRNA (d, e and
f) detected by in situ hybridisation with 35S-labelled antisense RNA probe. (a and d) Low-power dark-field view of colon cancer. (b,
and e) Light-field view of the same areas of a and d. Both TIMP-1 and MMP-9 mRNA are located in malignant tumour stroma;
no signal is observed in m-alignant epithelium. Higher magnifications of the area bordered by arrows in b and e are shown in c and
f. MMP-9 mRNA was found in a circular pattern of stromal cells (c), while TIMP-1 mRNA localised primarily in fibroblast-like
stromal cells (f).
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Figure 3 MMP-9 mRNA expression (-, positive; 0, negative)
in primary human colorectal cancer in relation to Dukes' stage.
positive for MMP-9 mRNA expression in liver metastases
have a circular morphology (Figure 6a) and were identified
as macrophages by immunostaining of adjacent sections
with anti-macrophage antibody (Figure 6b). As noted, not
all macrophages were positive for MMP-9 mRNA expression.
Discussion
Our present in situ hybridisation results are consistent with
our prior Northern blot demonstration of MMP-9 and
TIMP-1 mRNA overexpression in primary colorectal cancer
and liver metastases (Zeng et al., 1993). Our striking novel
observation is the distinct spatial expression of MMP-9 and
TIMP-1 mRNA within pericancer stroma in both primary
colorectal cancer and liver metastases. Our findings provide
1771...
W
M-9 and TI-i-1 mRNA in colon cancw and ve meletastase
ZS Zeng and JG GuilemGu
579
NL
.'
4.1
C
Figure 4 MMP-9 mRNA expression in liver metastases from
colorectal cancer. Sections were hybridised with a 35S-labelled
antisense RNA probe specific for MMP-9 mRNA. Dark-field (a)
and bright-field (b) microphotographs demonstrate MMP-9
mRNA expression limited to the interface between liver mnetas-
tases lesion (LM) and normal liver (NL). Higher magnification of
the area bordered by arrows in b suggests that MMP-9 mRNA-
positive stroma cells have a circular morphology (c).
the evidence that MMP-9 and TIMP-1 mRNA are pred-
ominantly stromal in origin in both primary colorectal
cancer and liver metastases. To our knowledge, this is the
first report demonstrating a distinct spatial expression of
MMP-9 and TIMP-1 mRNA in liver metastases from col-
orectal cancers.
MMP-9 is produced in vitro by a variety of cell types,
including fibroblasts, endothelial cells, keratinocytes, mac-
rophages and chondrocytes (Werb and Alexander, 1993).
The synthesis of MMP-9 has been induced by SV-40 trans-
formation of human fibroblasts (Wilhelm et al., 1989).
Under normal circumstances this enzyme is a major secre-
tion product of tissue macrophages (Wilhelm et al., 1989)
and has been found in the granules of polymorphonuclear
leucocytes and in cultured keratinocytes (Wilhelm et al.,1989).
In human granuloma annulare and necrobiosis lipoidica
diabeticorum, MMP-9 is expressed in eosinophils (Saari-
alho-Kere et al., 1993). Our observation that MMP-9
mRNA may be produced by peritumour macrophages is
consistent with a study (Pyke et al., 1993) in which MMP-9
was found in stroma cells of colorectal cancers. Similar to
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Fgre 5 TIMP-1 mRNA expression in liver metastases from
colorectal cancer. Sections were hybridised with a 3sS-labelled
antisense RNA probe specific for TIMP-I mRNA. Dark-field (a)
and bright-field (b) microphotographs demonstrate TIMP-1 sig-
nals principally in malignant tumour stroma. No signal is
observed in malignant epithelium. Higher magnification of the
area bordered by arrows in b reveals TIMP-1 mRNA to be
located in fibroblastlike stromal cells (c).
colon cancers, in situ hybridisation studies have shown
MMP-9 mRNA to be localised in the stroma of breast
(Davies et al., 1993a) and bladder cancers (Davies et al..
1993b). In human skin cancer, six of nine squamous cell
carcinomas expressed MMP-9 mRNA (Pyke et al., 1992).
However, none ofthe basal cell carcinomas, a rarely metastatic
tumour, expressed MMP-9 mRNA (Pyke et al., 1992).
The role for several metalloproteinases in colorectal
tumorigenesis is supported by Newell et al. (1994) who
demonstrated matrilysin (MMP-7) expression in both ben-
ign and malignant colorectal tumour. However, the expres-
sion of stromelysin- (MMP-3), stromelysin-3 (MMP-11)
and MMP-2 was noted only in colorectal cancer. These
findings suggest that MMP-7 expression is an early event
and that MMP-3, MMP-l 1 and MMP-2 expression is
bMMP-9 and TIMP-1 mRNA in colon cancer and mer me ms x - ZS Zeng and JG GuiHem
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a
]Figue 6 Identification of MMP-9 mRNA-positive cells. Serial
sections of a liver metastases were hybridised with a 35S-labelled
antisense RNA probe specific for MMP-9 mRNA or stained with
a macrophage-specific monoclonal antibody KIPl (CD68). (a) In
situ hybridisation. Cells positive for MMP-9 mRNA have a
macrophage-like morphology. (b) Immiunohistochemical staining.
MMP-9 miRNA-positive cells were identified as macrophages by
immunostaining of adjacent sections. As noted, not all mac-
rophages are positive for MMP-9 mRNA expression.
primarily a late event in colorectal tumorigenesis. The focal
expression of MMP-9 at the interface between liver metas-
tases and normal liver and its apparent macrophage onigin
reported here suggest an important role for macrophages in
degrading the extracellular matrix of colorectal cancer liver
metastases.
TIMP-1 is expressed in vitro by numerous cell types,
including fibroblasts (Stricklin and Welgus, 1983), chond-
rocytes (Gavrilovic et at., 1987) and endothelial (Herron et
at., 1988), and vascular smooth muscle cells (DeClerck,
1988). Analysis of human colorectal cancer specimen
homogenates have demonstrated an overexpression of both
TIMP-1 mRNA and protein when compared with normal
colonic mucosa (Guillem et at., 1990; Lu et at., 1991; Zeng
et at., 1995). In this study, we have found that, in human
colorectal cancer, TIMP-1 mRNA is located in fibroblast-
like stromal cells. A previous study on human granuloma
annulare and necrobiosis lipoidica diabeeticorum demon-
strated TIMP-1 mRNA expression in spindle-shaped cells
(Saarialho-Kere et al., 1993), suggesting that fibroblasts
may serve as a source for TIMP-1. Our in situ hybridisation
data are consistent with a study by Hewitt et al. (1991)
which demonstrated increased protein expression of col-
lagenase and TIMP-1 in colorectal cancers compared with
adenomas and normal mucosa. The strongest immunohisto-
chemical collagenase and TIMP signals were noted close to
islands of neoplastic cells. Furthermore, in this study, the
staining intensity in the invasive edge increased for coll-
agenase but decreased for TIMP (Hewitt et al., 1991).
Parallel overexpression of TIMP-1 and MMP-9 mRNA
noted in primary colorectal cancer and liver metastases
homogenates (Zeng et al., 1993) suggests possible co-
regulation of these two important genes in vivo. Although
the expression of several MMPs (MMP-2,-3,-7,-9 and -II) is
elevated in colorectal cancer (Newell et al., 1994), the dis-
tinct pattern of cellular TIMP-1 and MMP-9 expression
noted by in situ hybridisation suggests that elevated TIMP-1
expression may not be simply a response to local increases
in MMP-9 expression. This notion is supported by the fact
that TIMP-1 has growth-promoting properties (Gasson et
al., 1985; Avalos et al., 1988; Bertaux et al., 1991).
Hayakawa et al. (1992) have found that TIMP-1 accounts
for a significant portion of the growth factor activity of
serum and is capable of stimulating a wide range of human
and bovine cell lines, including those derived from tumours
(human breast adenocarcinoma, erythroleukaemia, myelo-
genous leukaemia and Burkitt's lymphoma). These data,
along with the recent observation that TIMP-1 stimulates
the secretion of collagenase from human skin fibroblasts
(Clark et al., 1994), suggest that, in addition to its role as a
metalloproteinase inhibitor, TIMP-1 may also function as a
growth factor in the pathogenesis of a variety of diseases.
The mechanism of TIMPs' multiple function is presently
unknown. However, it is postulated that the domains res-
ponsible for growth factor activity are physically distinct
from those responsible for regulating metalloproteinase
activity (Docherty et al., 1992; Stetler-Stevenson et al.,
1992).
In conclusion in situ hybnrdisation analysis has shown dis-
tinct patterns of TIMP-1 and MMP-9 mRNA expression in
both primary colorectal cancer and liver metastases. Our
results demonstrate that MMP-9 and TIMP-1 mRNA are
produced not by colorectal cancer cells themselves, but rather
by surrounding macrophages and fibroblast-like cells respec-
tively. In addition, the distinct, non-juxtaposed pattern of
MMP-9 and TIMP-1 expression suggests that TIMP-1 may
not be produced simply in response to local elevations of
MMP-9 and suggests that in vivo these genes are
independently regulated. Further studies are needed to define
the colorectal cancer-stroma cell interactions involved in the
regulation of MMPs and TIMP productions.
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